{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/crohns-disease/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"1a920dcd-3a15-527f-9fc2-97be951c56cc","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field 5abee061-67c7-4fd7-a004-85916ecf9b33 --><h2>Update</h2><!-- end field 5abee061-67c7-4fd7-a004-85916ecf9b33 -->","summary":null,"htmlStringContent":"<!-- begin item e79d106b-a7fd-4250-b2fe-038dd415c3ce --><!-- end item e79d106b-a7fd-4250-b2fe-038dd415c3ce -->","topic":{"id":"a55bf0e9-c7ea-505e-b7ff-5093105336e5","topicId":"7057d96d-a527-4391-84a1-c39953de3eae","topicName":"Crohn's disease","slug":"crohns-disease","lastRevised":"Last revised in August 2020","chapters":[{"id":"9c1b7d20-f572-5a3c-845f-3f4b65f646e1","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"6b9f2bb0-4b7b-5373-ace6-15e38cc8904f","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"2a50fc53-dced-5bb1-83cf-20d5ce4f9e8e","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"a5629107-6649-5a0c-a706-90ad8bf14aa7","slug":"changes","fullItemName":"Changes"},{"id":"1a920dcd-3a15-527f-9fc2-97be951c56cc","slug":"update","fullItemName":"Update"}]},{"id":"79cdca68-ce3a-5435-bca1-8393c4d809a6","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"123f065a-c1e6-59ef-a0f6-fa3212214c90","slug":"goals","fullItemName":"Goals"},{"id":"d3e5c61e-a5b9-586a-8698-69a0c0f79a5f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b41011e0-33e6-52d3-9434-5f29d0baeeb8","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"f3bcc082-58a6-51db-a805-173080268884","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"a5948dc8-4eac-58f3-8d64-68a80aeb4059","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"7082be71-4889-5e95-bd5f-27917f361203","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"65c06b36-b686-57f1-be7f-6fae62c4deb0","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"3fa00303-9d62-51cf-819b-dbad0041831e","slug":"definition","fullItemName":"Definition"},{"id":"6890604a-a1f2-5be2-94b0-d2471c85fdbc","slug":"causes-risk-factors","fullItemName":"Causes and risk factors"},{"id":"0d0050de-d075-540a-9c7c-ed50c6ed1243","slug":"prevalence","fullItemName":"Prevalence"},{"id":"05aa7fe4-c9b9-51f0-bf41-2369861eba6c","slug":"complications","fullItemName":"Complications"},{"id":"67cb018a-e79e-5636-bd84-67fe57bf28c2","slug":"extra-intestinal-manifestations","fullItemName":"Extra-intestinal manifestations"},{"id":"d2c1974d-3136-58a1-b5ba-55826ab8a286","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"14a7e92b-d43e-5b64-b357-c1a4d063afb3","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"32cf487b-92a9-5d33-949e-023023aede46","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"5440444f-1635-5240-bea3-54d84e6067f5","slug":"investigations","fullItemName":"Investigations"},{"id":"f7a2e718-21ad-5956-a862-8f8406ca2f8b","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"a49169c9-856e-51c3-94cc-76e3f02f6073","fullItemName":"Management","slug":"management","subChapters":[{"id":"c4ee1de2-52a2-5289-82bd-c3377ae84b6c","slug":"suspected-crohns-disease","fullItemName":"Scenario: Suspected Crohn's disease"},{"id":"b3e71531-764c-58b2-aa02-ece1993fb53f","slug":"confirmed-crohns-disease","fullItemName":"Scenario: Confirmed Crohn's disease"},{"id":"b822e9cd-227b-54db-9bfd-57cf52a4e663","slug":"fertility-pregnancy-breastfeeding-with-crohns-disease","fullItemName":"Scenario: Fertility, pregnancy, and breastfeeding with Crohn's disease"},{"id":"9a2be3f2-65c0-5e62-9b89-9aef0f5df386","slug":"covid-19","fullItemName":"Scenario: COVID-19"}]},{"id":"82ab51ab-f7f0-5464-a0dc-cb566bb3f629","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"771b1e3f-3c10-5c86-bbb4-5ff669ca2d44","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"fb296c54-fd91-56fc-ab19-6fd4bb759030","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"efff8f5f-5a26-5e56-a428-b3155279fcef","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"420029a0-c51b-5ffc-a7f3-71940eccb5ba","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"09872916-a68f-57e9-b064-aab1b782ca32","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"dc3e796d-dda1-58f4-b43f-f4ce100ebfc2","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a0922fda-b50c-5cff-8ccd-19fef4fe47f1","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"2a50fc53-dced-5bb1-83cf-20d5ce4f9e8e","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"c71cc9fe-76ca-5259-acea-fa4ae2193de6","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field 974b684e-28b8-4068-acea-e56d5752bc6b --><h3>New evidence</h3><!-- end field 974b684e-28b8-4068-acea-e56d5752bc6b -->","summary":null,"htmlStringContent":"<!-- begin item 8e3b6428-0133-480a-84ab-98cdb0b640f2 --><!-- begin field 6ddd3ca9-8977-4177-ade5-1af03937dce8 --><h3>Evidence-based guidelines</h3><!-- end field 6ddd3ca9-8977-4177-ade5-1af03937dce8 --><!-- begin field c508bf0e-f766-490b-9f90-c81d679e354f --><ul><li>BSG (2019) <em>BSG consensus guidelines on the management of inflammatory bowel disease in adults. British Society of Gastroenterology. </em><a data-hyperlink-id=\"683f6924-aa5c-4da1-82f8-aa8100d1e0e7\" href=\"https://www.bsg.org.uk/\">www.bsg.org.uk</a> [<a data-hyperlink-id=\"a71bdc43-91d4-476a-a6ee-aa8100d1e13c\" href=\"https://www.bsg.org.uk/resource/bsg-consensus-guidelines-ibd-in-adults.html\">Free Full-text</a>] </li></ul><!-- end field c508bf0e-f766-490b-9f90-c81d679e354f --><!-- begin field 1ad6a469-627a-40f9-b68d-7ac569c296f9 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field 1ad6a469-627a-40f9-b68d-7ac569c296f9 --><!-- begin field a1cb0026-621e-4dc0-b4cc-71e5a757a325 --><p>No new HTAs since 1 May 2019.</p><!-- end field a1cb0026-621e-4dc0-b4cc-71e5a757a325 --><!-- begin field 8abd8913-bb72-4b0a-985b-5a7ac44ef162 --><h3>Economic Appraisals</h3><!-- end field 8abd8913-bb72-4b0a-985b-5a7ac44ef162 --><!-- begin field 3e97ebe8-4b9e-47a9-82b4-a6a024980940 --><p>No new economic appraisals relevant to England since 1 May 2019.</p><!-- end field 3e97ebe8-4b9e-47a9-82b4-a6a024980940 --><!-- begin field bb2a1fab-76e6-4704-88d3-b6bc8ccf93c9 --><h3>Systematic reviews and meta-analyses</h3><!-- end field bb2a1fab-76e6-4704-88d3-b6bc8ccf93c9 --><!-- begin field 9b821452-2697-4d40-a3d6-df5daafd739c --><p>No new systematic reviews published since 1 May 2019.</p><!-- end field 9b821452-2697-4d40-a3d6-df5daafd739c --><!-- begin field a56e890f-d96a-457b-bfea-1cda64f468fb --><h3>Primary evidence</h3><!-- end field a56e890f-d96a-457b-bfea-1cda64f468fb --><!-- begin field fe504416-55f7-4361-8355-c418483e5880 --><p>No new randomized controlled trials published since 1 May 2019.</p><!-- end field fe504416-55f7-4361-8355-c418483e5880 --><!-- end item 8e3b6428-0133-480a-84ab-98cdb0b640f2 -->","subChapters":[]},{"id":"54cccf55-f805-544a-bcc8-a5b0016a78e4","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field c4e5bf8a-68d9-44b7-a5f5-db72e36e10e8 --><h3>New policies</h3><!-- end field c4e5bf8a-68d9-44b7-a5f5-db72e36e10e8 -->","summary":null,"htmlStringContent":"<!-- begin item 5680a9cc-5b07-46b9-81b0-ee135327140a --><!-- begin field 10ddae26-601c-41f2-8ba8-f09c3f5bd9b2 --><p>No new national policies or guidelines since 1 May 2019.</p><!-- end field 10ddae26-601c-41f2-8ba8-f09c3f5bd9b2 --><!-- end item 5680a9cc-5b07-46b9-81b0-ee135327140a -->","subChapters":[]},{"id":"6baddbde-6e83-5bd3-bddb-b6e61608f7a2","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field e934b3b9-490b-4e49-98d5-be0b62c80735 --><h3>New safety alerts</h3><!-- end field e934b3b9-490b-4e49-98d5-be0b62c80735 -->","summary":null,"htmlStringContent":"<!-- begin item af5e7e39-c62d-4d32-a8cf-f506a459408b --><!-- begin field 2d12ea55-304d-446e-9151-22dac31d9ee0 --><p>No new safety alerts since 1 May 2019.</p><!-- end field 2d12ea55-304d-446e-9151-22dac31d9ee0 --><!-- end item af5e7e39-c62d-4d32-a8cf-f506a459408b -->","subChapters":[]},{"id":"bb164a32-060a-51d7-a2eb-35921ef701e3","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field 75743abe-7d58-4105-9d29-fdde6df9724b --><h3>Changes in product availability</h3><!-- end field 75743abe-7d58-4105-9d29-fdde6df9724b -->","summary":null,"htmlStringContent":"<!-- begin item ba6a6dbc-054e-47e7-b7c9-624b48fe53e9 --><!-- begin field 9f3f90fa-ec23-4539-b1e0-fede9e76b3b1 --><ul><li>Hulio has comparable quality, safety and efficacy to Humira (reference product). It will be licenced for arthritis (rheumatoid, juvenile idiopathic and psoriatic), axial spondyloarthritis, psoriasis, hidradenitis suppurativa Crohn’s disease, ulcerative colitis and uveitis. See <a data-hyperlink-id=\"ac296853-2ea9-4f75-a3da-a93400a40120\" href=\"http://www.ema.europa.eu/docs/en_GB/document_library/Summary_of_opinion_-_Initial_authorisation/human/004429/WC500252511.pdf\">here</a> for more information. </li></ul><!-- end field 9f3f90fa-ec23-4539-b1e0-fede9e76b3b1 --><!-- end item ba6a6dbc-054e-47e7-b7c9-624b48fe53e9 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}